(Q34580159)

3 August 2017

Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial (English)

1 reference

3 August 2017

John Watson

7

0 references

Bruce Neal

Bruce Neal

18

0 references

Sophia Zoungas

Sophia Zoungas

3

0 references

Craig S. Anderson

Craig Anderson

11

0 references

John Chalmers

John Chalmers

17

0 references

Giuseppe Mancia

14

Giuseppe Mancia

1 reference

3 August 2017

9

Andre Pascal Kengne

1 reference

3 August 2017

1

Jun Hata

1 reference

3 August 2017

10

Toshiharu Ninomiya

1 reference

3 August 2017

15

Neil Poulter

1 reference

3 August 2017

2

Hisatomi Arima

1 reference

3 August 2017

4

Greg Fulcher

1 reference

3 August 2017

8

Rohina Joshi

1 reference

3 August 2017

13

Anushka Patel

1 reference

3 August 2017

16

Stephen MacMahon

1 reference

ADVANCE-ON Collaborative Group

3 August 2017

19

ADVANCE Collaborative Group

1 reference

3 August 2017

Carol Pollock

5

1 reference

3 August 2017

Mark Adams

6

1 reference

3 August 2017

Mark Woodward

12

1 reference

3 August 2017

language of work or name

English

0 references

publication date

4 February 2013

1 reference

3 August 2017

1 reference

3 August 2017

8

1 reference

3 August 2017

e55807

1 reference

3 August 2017

2

1 reference

Creative Commons Attribution 4.0 International

3 August 2017

start time

4 February 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563633

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563633

Do we need to adjudicate major clinical events?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563633

Comparing classifications of death in the Mode Selection Trial: agreement and disagreement among site investigators and a clinical events committee

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563633

Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563633

Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563633

Systematic adjudication of myocardial infarction end-points in an international clinical trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563633

The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial: results with and without the end-point committee's final decision on end-points

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563633

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

7 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055807

Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055807

Outcome assessment for clinical trials: how many adjudicators do we need? Canadian Lung Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055807

Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation

21 January 2018

2 references

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055807

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563633

Validation of primary and secondary outcomes and classification of mode of death among patients with clinical evidence of heart failure after a myocardial infarction: a report from the Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3563633

10.1371/JOURNAL.PONE.0055807

27 October 2018

Identifiers

DOI

1 reference

3 August 2017

0 references

1 reference

3 August 2017

1 reference